
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2018 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2023 | 0 | 1.344.000 | 0 | 1 | ||
| 2020 | 0 | 2.484.000 | 55.200 | 1 | ||
| 2018 | 0 | 8.273.559 | 947.245 | 2 | ||
Total number of partners: 72
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 72
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2023-01-01 | Biomedical Technologies and Innovation Doctoral Programme | BIOTIN | participant | 1.344.000 | 29 |
| 2020-04-01 | proactive monitoring of cancer as an alternative to surgery | PRISAR2 | participant | 2.484.000 | 25 |
| 2018-10-01 | Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants | MgSafe | participant | 3.956.399 | 13 |
| 2018-10-01 | Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma. | EDIT | participant | 4.317.160 | 9 |